Market closed
Coya Therapeutics, Inc./$COYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Ticker
$COYA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
8
Website
COYA Metrics
BasicAdvanced
$103M
-
-$0.98
0.32
-
Price and volume
Market cap
$103M
Beta
0.32
52-week high
$8.29
52-week low
$4.65
Average daily volume
80K
Financial strength
Current ratio
11.585
Quick ratio
10.216
Management effectiveness
Return on assets (TTM)
-25.15%
Return on equity (TTM)
-39.57%
Valuation
Price to revenue (TTM)
26.498
Price to book
2.61
Price to tangible book (TTM)
2.61
Price to free cash flow (TTM)
-9.131
Growth
Revenue change (TTM)
-40.79%
Earnings per share change (TTM)
24.25%
3-year earnings per share growth (CAGR)
-19.74%
COYA News
AllArticlesVideos
Coya Therapeutics: Treg Proof-Of-Concept Continues With Interim FTD Data Release
Seeking Alpha·2 days ago
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Business Wire·3 days ago
Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Coya Therapeutics, Inc. stock?
Coya Therapeutics, Inc. (COYA) has a market cap of $103M as of April 27, 2025.
What is the P/E ratio for Coya Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Coya Therapeutics, Inc. (COYA) stock is 0 as of April 27, 2025.
Does Coya Therapeutics, Inc. stock pay dividends?
No, Coya Therapeutics, Inc. (COYA) stock does not pay dividends to its shareholders as of April 27, 2025.
When is the next Coya Therapeutics, Inc. dividend payment date?
Coya Therapeutics, Inc. (COYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Coya Therapeutics, Inc.?
Coya Therapeutics, Inc. (COYA) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.